Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

COVID-19 affects many body systems, causing a wide range of symptoms and complications.

Skin aging reflects overall body aging and can indicate internal health conditions.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Female pattern hair loss often starts in teenage years, reduces hair density, and can impact quality of life.

People with Birt-Hogg-Dubé syndrome often have lung problems and delayed diagnosis, and better recognition of CT scan signs could improve diagnosis and management.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Skin issues can indicate immune system problems.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

Pincer nails are rare in lupus patients and may be managed conservatively.

COVID-19 affects multiple body systems, not just the lungs.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

A rare form of lupus caused hair loss and skin bumps, diagnosed through biopsy, improved partially with treatment.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

SLE significantly affects daily life, especially through fatigue and joint pain, highlighting the need for better treatments.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Looking at skin can help find and treat serious diseases early.

Lupus can be a rare cause of high calcium levels in the blood.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.